Synopsis
This volume attemptsto provide the formulation scientist with casehistories involving the use of therapeutic proteins and peptides that have been mar- keted or are under clinical testing. In previous volumes of this series, funda- mental theories and principles ofprotein characterization and stability were presented in depth by researchers in their fieldsofexpertise. The way from theory to practice isnot alwaysobvious and straightforward. There isa need for practical examples of how the principles and theories are put into use, specificallyin the development of a pharmaceutical product. It is our hope that this volume will fulfillsuch a need. Itisnot asimple task to choose a panel ofproteinsand peptides from the over 200 agents in human clinical trials. We have tried to collect a wide representation of molecules of different sizes-from 10 amino acids (Leu- prolide) to 1020 amino acids (Muromonab CD3). The examples include agents derived from various sources including monoclonal antibodies (Mur- omonab CD3), recombinant DNA (human and bovine growth hormones), natural source (fibrolase), and chemical synthesis (Leuprolide). Clearly this list is not intended to be encyclopedic. It isthe first time a collection of this sort has been made accessibleto the formulation scientists involved in devel- oping protein and peptide products. Although each chapter in this volume focuses primarily on the charac- terization and stability of a specific molecule, each has unique aspects.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Autres éditions populaires du même titre
Résultats de recherche pour Stability and Characterization of Protein and Peptide...
Image d'archives
Stability and Characterization of Protein and Peptide Drugs: Case Histories (Pharmaceutical Biotechnology, 5)
Edité par
Springer, 1993
ISBN 10 : 0306443651
ISBN 13 : 9780306443657
Ancien ou d'occasion
Couverture rigide
Vendeur : thebookforest.com, San Rafael, CA, Etats-Unis
Évaluation du vendeur 4 sur 5 étoiles
Etat : Like New. Page block firm and clean, binding unblemished, boards straight, no markings of any kind. Fine, like new condition. Well packaged and promptly shipped from California. US veteran operated. N° de réf. du vendeur BAY_00_SH_070336
Acheter D'occasion
EUR 9,30
Expédition à EUR 4,33
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Stability and Characterization of Protein and Peptide Drugs: Case Histories (Pharmaceutical Biotechnology, 5)
Edité par
Springer, 1993
ISBN 10 : 0306443651
ISBN 13 : 9780306443657
Ancien ou d'occasion
Couverture rigide
Vendeur : Phatpocket Limited, Waltham Abbey, HERTS, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions. N° de réf. du vendeur Z1-B-011-01646
Acheter D'occasion
EUR 5,11
Expédition à EUR 12,32
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Stability and Characterization of Protein and Peptide Drugs: Case Histories (Pharmaceutical Biotechnology, 5)
Edité par
Springer, 1993
ISBN 10 : 0306443651
ISBN 13 : 9780306443657
Ancien ou d'occasion
Couverture rigide
Vendeur : Ammareal, Morangis, France
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : Très bon. Ancien livre de bibliothèque avec équipements. Edition 1993. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Edition 1993. Ammareal gives back up to 15% of this item's net price to charity organizations. N° de réf. du vendeur G-042-765
Acheter D'occasion
EUR 6,10
Expédition à EUR 16,50
Expédition depuis France vers Etats-Unis
Expédition depuis France vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Pharmaceutical Biotechnology: Stability and Characterization of Protein and Peptide Drugs: Case Histories (Volume 5)
Edité par
Plenum Press, 1993
ISBN 10 : 0306443651
ISBN 13 : 9780306443657
Ancien ou d'occasion
Couverture rigide
Vendeur : Anybook.com, Lincoln, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : Good. Volume 5. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,850grams, ISBN:0306443651. N° de réf. du vendeur 8682846
Acheter D'occasion
EUR 31,12
Expédition à EUR 15,75
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Stability and Characterization of Protein and Peptide Drugs: Case Histories (Pharmaceutical Biotechnology, 5)
Edité par
Springer, 1993
ISBN 10 : 0306443651
ISBN 13 : 9780306443657
Ancien ou d'occasion
Couverture rigide
Edition originale
Vendeur : Karl Theis, Torrance, CA, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Hardcover. Etat : Near Fine. 1st Edition. A LIKE NEW UNMARKED BOOK WITH A SUN FADED SPINE. N° de réf. du vendeur 046481
Acheter D'occasion
EUR 89,35
Expédition à EUR 4,99
Expédition nationale : Etats-Unis
Expédition nationale : Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Stability and Characterization of Protein and Peptide Drugs
impression à la demandeVendeur : moluna, Greven, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Gebunden. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Stability and Characterization of Human Growth Hormone R. Pearlman, T.A. Bewley. Characterization and Formulation Considerations for Recombinantly-Derived Bovine Somatotropin S.R. Davis, M.J. Hageman. Stability Characterization and Formulation Develop. N° de réf. du vendeur 5902045
Acheter neuf
EUR 180,07
Expédition à EUR 48,99
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Stability and Characterization of Protein and Peptide Drugs
Edité par
Springer US Mai 1993, 1993
ISBN 10 : 0306443651
ISBN 13 : 9780306443657
Neuf
Couverture rigide
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This volume attemptsto provide the formulation scientist with casehistories involving the use of therapeutic proteins and peptides that have been mar keted or are under clinical testing. In previous volumes of this series,funda mental theories and principles ofprotein characterization and stability were presented in depth by researchers in their fieldsofexpertise. The way from theory to practice isnot alwaysobvious and straightforward. There isa need for practical examples of how the principles and theories are put into use, specificallyin the development of a pharmaceutical product. It is our hope that this volume will fulfillsuch a need. Itisnot asimple task to choose a panel ofproteinsand peptides from the over 200 agents in human clinical trials. We have tried to collect a wide representation of molecules of different sizes-from 10 amino acids (Leu prolide) to 1020 amino acids (Muromonab CD3). The examples include agents derived from various sources including monoclonal antibodies (Mur omonab CD3), recombinant DNA (human and bovine growth hormones), natural source (fibrolase), and chemical synthesis (Leuprolide). Clearly this list is not intended to be encyclopedic. It isthe first time a collection of this sort has been made accessibleto the formulation scientists involved in devel oping protein and peptide products. Although each chapter in this volume focuses primarily on the charac terization and stability of a specific molecule, each has unique aspects. 380 pp. Englisch. N° de réf. du vendeur 9780306443657
Acheter neuf
EUR 213,99
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image d'archives
Stability and Characterization of Protein and Peptide Drugs: Case Histories (Pharmaceutical Biotechnology, 5)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9780306443657_new
Acheter neuf
EUR 225,44
Expédition à EUR 13,87
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Stability and Characterization of Protein and Peptide Drugs | Case Histories
impression à la demandeVendeur : preigu, Osnabrück, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. Stability and Characterization of Protein and Peptide Drugs | Case Histories | Y. John Wang (u. a.) | Buch | xxii | Englisch | 1993 | Springer US | EAN 9780306443657 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. N° de réf. du vendeur 102553505
Acheter neuf
EUR 186,70
Expédition à EUR 70
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 5 disponible(s)
Image fournie par le vendeur
Stability and Characterization of Protein and Peptide Drugs
Edité par
Springer US, Springer US Mai 1993, 1993
ISBN 10 : 0306443651
ISBN 13 : 9780306443657
Neuf
Couverture rigide
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -This volume attemptsto provide the formulation scientist with casehistories involving the use of therapeutic proteins and peptides that have been mar keted or are under clinical testing. In previous volumes of this series,funda mental theories and principles ofprotein characterization and stability were presented in depth by researchers in their fieldsofexpertise. The way from theory to practice isnot alwaysobvious and straightforward. There isa need for practical examples of how the principles and theories are put into use, specificallyin the development of a pharmaceutical product. It is our hope that this volume will fulfillsuch a need. Itisnot asimple task to choose a panel ofproteinsand peptides from the over 200 agents in human clinical trials. We have tried to collect a wide representation of molecules of different sizes-from 10 amino acids (Leu prolide) to 1020 amino acids (Muromonab CD3). The examples include agents derived from various sources including monoclonal antibodies (Mur omonab CD3), recombinant DNA (human and bovine growth hormones), natural source (fibrolase), and chemical synthesis (Leuprolide). Clearly this list is not intended to be encyclopedic. It isthe first time a collection of this sort has been made accessibleto the formulation scientists involved in devel oping protein and peptide products. Although each chapter in this volume focuses primarily on the charac terization and stability of a specific molecule, each has unique aspects.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 380 pp. Englisch. N° de réf. du vendeur 9780306443657
Acheter neuf
EUR 213,99
Expédition à EUR 60
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)